Duchenne Muscular Dystrophy News and Research

RSS
Duchenne muscular dystrophy (DMD) is a progressive muscle disorder that causes the loss of both muscle function and independence. DMD is perhaps the most prevalent of the muscular dystrophies and is the most common lethal genetic disorder diagnosed during childhood today. Each year, approximately 20,000 children worldwide are born with DMD (one of every 3,500 male children).
Lab grown, self-renewing muscle stem cells can repair muscle tissue damage in mice

Lab grown, self-renewing muscle stem cells can repair muscle tissue damage in mice

Using CRISPR/Cas to develop biosafety materials

Using CRISPR/Cas to develop biosafety materials

Reactivating Piezo1 protein could help repair broken down, dystrophic muscles

Reactivating Piezo1 protein could help repair broken down, dystrophic muscles

Cellular therapy offers promise for patients with Duchenne muscular dystrophy, trial shows

Cellular therapy offers promise for patients with Duchenne muscular dystrophy, trial shows

Glucocorticoid steroids improve muscle performance through distinct, sex-specific molecular pathways

Glucocorticoid steroids improve muscle performance through distinct, sex-specific molecular pathways

Inside the tactical tug of war over the controversial Alzheimer’s drug

Inside the tactical tug of war over the controversial Alzheimer’s drug

Study reveals link between muscular dystrophy and sphingolipids

Study reveals link between muscular dystrophy and sphingolipids

Novel gene therapy for diseased muscle fiber repair

Novel gene therapy for diseased muscle fiber repair

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene

New consensus-based recommendations designed to improve quality of life for DMD patients

New consensus-based recommendations designed to improve quality of life for DMD patients

First pediatric-only guidelines for the use of pacemakers and implantable defibrillators

First pediatric-only guidelines for the use of pacemakers and implantable defibrillators

Study shows long-term safety and biologic activity of golodirsen in DMD patients

Study shows long-term safety and biologic activity of golodirsen in DMD patients

Researchers illustrate the importance and value of sharing negative research results

Researchers illustrate the importance and value of sharing negative research results

Parent Project Muscular Dystrophy successfully completes the Newborn Screening Pilot project

Parent Project Muscular Dystrophy successfully completes the Newborn Screening Pilot project

Specialized cells that keep the heart beating have ability to regenerate after birth, study reveals

Specialized cells that keep the heart beating have ability to regenerate after birth, study reveals

Early treatment with ACE inhibitors improves cardiac outcomes of patients with Becker muscular dystrophy

Early treatment with ACE inhibitors improves cardiac outcomes of patients with Becker muscular dystrophy

New gene-delivering workhorse could make gene therapy safer, more effective for muscle diseases

New gene-delivering workhorse could make gene therapy safer, more effective for muscle diseases

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

A path to treat currently untreatable cases of cystic fibrosis is clearly achievable, study suggests

Dying patients with rare diseases struggle to get experimental therapies

Dying patients with rare diseases struggle to get experimental therapies

Anti-inflammatory nanoparticles could be applied to the weakening muscles of DMD patients

Anti-inflammatory nanoparticles could be applied to the weakening muscles of DMD patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.